From the reports of previous studies and our study on [177Lu]Lu-DOTA.SA.FAPi [3,7], it is evident that the main challenge for the potential therapeutic application of the FAP tracers was to optimize its tumor retention time. The gene discussed is FAP; the disease is neoplasm.